Press Releases
Warwick gets share of £2.6 million research funding from Diabetes UK
Diabetes UK has committed to invest £2.6 million in 19 brand new projects including one at the University's School of life Sciences.
Warwick-backed state-of-the-art cryo-electron microscopy facility opened
A new state-of-the-art Cryo-Electron Microscope (Cryo-EM) facility that will advance the understanding of the processes of life has been officially opened.
Professor Laura Green appointed to BBSRC Council
Professor Laura Green OBE, Deputy Pro Vice Chancellor (Research) at the University of Warwick, has been appointed to the Council of the Biotechnology and Biological Sciences Research Council (BBSRC).
‘Chameleon’ ocean bacteria can shift their colours
Cyanobacteria - which propel the ocean engine and help sustain marine life – can shift their colour like chameleons to match different coloured light across the world’s seas, according to research by an international collaboration including the University of Warwick.
VirionHealth Receives up to $4.2m from DARPA
University of Warwick spin-out company, VirionHealth - a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA).
Most people in favour of screening for spinal muscular atrophy
Research from the University of Warwick indicates that most people are in favour of newborn screening for the potentially deadly condition spinal muscular atrophy (SMA).
SMA is an inherited neuromuscular disorder with a wide spectrum of severities and is a leading genetic cause of infant death worldwide. However, there is no routine screening programme for SMA in the UK.